Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marko Jakopovic

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Expert Opinion on Biological Therapy|June 1, 2014
Immunotherapy for non-small-cell lung cancerAnish Thomas, Marko Jakopovic
Anticancer Research|January 10, 2014
From platinum compounds to targeted therapies in advanced thoracic malignanciesMarko Jakopovic, Anish Thomas, Ariel Lopez-Chavez
Frontiers in Oncology|June 16, 2015
Trends and Characteristics of Young Non-Small Cell Lung Cancer Patients in the United StatesAnish Thomas, Yuanbin Chen, Tinghui Yu, et al.
Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace|June 5, 2019
Metastatic cancer mimics interstitial lung disease. Cases when we need fast diagnosis and treatmentAna Hecimovic, Marko Jakopovic, Andrea Vukic Dugac, et al.
Journal of Thoracic Disease|January 15, 2021
Immunotherapy for thymomaMarko Jakopovic, Lela Bitar, Fran Seiwerth, et al.
Wiener Klinische Wochenschrift|April 25, 2012
Acquired rhinophyma as a paraneoplastic manifestation of non-small cell lung cancerNeven Rakusic, Denis Baricevic, Nevena Rakusic, et al.
Caspian Journal of Internal Medicine|December 5, 2018
Hemothorax as the first manifestation of idiopathic pulmonary arteriovenous malformationMaja Crkvenac, Marko Jakopovic, Ana Hecimovic, et al.
Cancer Letters|August 23, 2005
Altered iron metabolism, transferrin receptor 1 and ferritin in patients with colon cancerMaja Prutki, Marija Poljak-Blazi, Marko Jakopovic, et al.
Frontiers in Oncology|October 17, 2013
Targeting the epigenome in lung cancer: expanding approaches to epigenetic therapyMarko Jakopovic, Anish Thomas, Sanjeeve Balasubramaniam, et al.
Anticancer Research|December 13, 2005
Concurrent radiotherapy and tumor targeting with 111In-HMFG1-F(ab')2 in patients with MUC1-positive non-small cell lung cancerMichael Garkavij, Miroslav Samarzija, Sven B Ewers, et al.
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Expert Opinion on Biological Therapy|June 1, 2014
Immunotherapy for non-small-cell lung cancerAnish Thomas, Marko Jakopovic
Anticancer Research|January 10, 2014
From platinum compounds to targeted therapies in advanced thoracic malignanciesMarko Jakopovic, Anish Thomas, Ariel Lopez-Chavez
Frontiers in Oncology|June 16, 2015
Trends and Characteristics of Young Non-Small Cell Lung Cancer Patients in the United StatesAnish Thomas, Yuanbin Chen, Tinghui Yu, et al.
Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace|June 5, 2019
Metastatic cancer mimics interstitial lung disease. Cases when we need fast diagnosis and treatmentAna Hecimovic, Marko Jakopovic, Andrea Vukic Dugac, et al.
Journal of Thoracic Disease|January 15, 2021
Immunotherapy for thymomaMarko Jakopovic, Lela Bitar, Fran Seiwerth, et al.
Wiener Klinische Wochenschrift|April 25, 2012
Acquired rhinophyma as a paraneoplastic manifestation of non-small cell lung cancerNeven Rakusic, Denis Baricevic, Nevena Rakusic, et al.
Caspian Journal of Internal Medicine|December 5, 2018
Hemothorax as the first manifestation of idiopathic pulmonary arteriovenous malformationMaja Crkvenac, Marko Jakopovic, Ana Hecimovic, et al.
Cancer Letters|August 23, 2005
Altered iron metabolism, transferrin receptor 1 and ferritin in patients with colon cancerMaja Prutki, Marija Poljak-Blazi, Marko Jakopovic, et al.
Frontiers in Oncology|October 17, 2013
Targeting the epigenome in lung cancer: expanding approaches to epigenetic therapyMarko Jakopovic, Anish Thomas, Sanjeeve Balasubramaniam, et al.
Anticancer Research|December 13, 2005
Concurrent radiotherapy and tumor targeting with 111In-HMFG1-F(ab')2 in patients with MUC1-positive non-small cell lung cancerMichael Garkavij, Miroslav Samarzija, Sven B Ewers, et al.
Pageof 4